background image

Paid Clinical Trials Bowling Green

Discover 56 paid clinical trials in Bowling Green, Kentucky. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

for
Diabetes Mellitus, Type 2, Hypertension,
Location: Bowling Green KY, Owensboro KY, Lexington KY,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07064473

Phase3, Recruiting
Active & Responsive

A Pivotal Study to Evaluate the Effectiveness of Isometric Handgrip Therapy in Elevated Blood Pressure and Hypertensive Subjects

for
Elevated Blood Pressure, Hypertension
Location: Bowling Green KY, Knoxville TN, Chicago IL,
Sponsor: Zona Health, Inc

Sex: All

Age: 22+

Code: NCT06843577

Recruiting
Active & Responsive

Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care

for
Arthritis, Rheumatoid
Location: Bowling Green KY, Huntsville AL, Tupelo MS,
Sponsor: Crescendo Bioscience

Sex: All

Age: 18 - 70+

Code: NCT02832297

Recruiting
Active & Responsive

A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

for
Atopic Dermatitis
Location: Bowling Green KY, Nashville TN, Mason OH,
Sponsor: Apogee Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07003425

Phase2, Recruiting
Active & Responsive

Phase 2b Study of EVO756 in Adults With Atopic Dermatitis

for
Atoptic Dermatitis
Location: Bowling Green KY, Murfreesboro TN, Clarksville IN,
Sponsor: Evommune, Inc.

Sex: All

Age: 18+

Code: NCT07150845

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

for
Psoriasis, Overweight or Obesity
Location: Bowling Green KY, Smyrna TN, Myrtle Beach SC,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06857942

Recruiting
Active & Responsive

An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis

for
Plaque Psoriasis
Location: Bowling Green KY, Detroit MI, London, Rockville MD,
Sponsor: Oruka Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07449702

Phase2, Recruiting
Active & Responsive

Safety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy as First-line or Second-line Treatment

for
Non-small Cell Lung Cancer
Location: Elizabethtown KY, Birmingham AL, Tampa FL, New York NY
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT06841055

Phase2, Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

for
NASH - Nonalcoholic Steatohepatitis,
Location: Hermitage TN, Clarksville TN, Nashville TN,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06528314

Phase3, Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

for
NASH With Fibrosis, MASH With Fibrosis
Location: Hermitage TN, Clarksville TN, Nashville TN,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06215716

Phase3, Recruiting